Mouthpiece1 Increase Covishield dose interval to 4-8 weeks
By Administrator_ India Capital Sands The government has increased the time interval between the two doses of Covishield — the Oxford-AstraZeneca vaccine against Covid-19, being manufactured locally by Serum Institute of India — from four-six weeks to four-eight weeks in view of the “emerging scientific evidence”. The recommendation came from the National Technical Advisory Group …